Pioglitazone on Pancreatic Steatosis and Bone Health

Effect of Pioglitazone on Pancreatic Steatosis and Bone Health

Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on pancreatic fat content and bone turnover markers.

Inclusion Criteria:

• Fat level in the pancreas above 4% (measurement done by us with an MRI)
• English speaker
• over 21 years old

Exclusion Criteria:

• contraindication to MRI
• anemia
• pregnancy or desire to conceive
• use of unapproved medications
• prior pancreatic disease
• use of more then 2 alcoholic drinks every day